Hims & Hers Health, Inc. (HIMS)

Healthcare
Drug Manufacturers - Specialty & Generic
United States
Yahoo Finance  •  Trading View  •  Company site
Price
$62.76
▲ 8.74 (16.18%)
Market Cap
$14,184,988,672
Shares: 215,939,037
P/E
41.43
P/B: 10.95
ROE
26.44%
Current Ratio: 1.79
Fundamentals Score
55 (NEUTRAL)

Company Overview

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Headquarters: 2269 Chestnut Street, San Francisco, CA, 94123, United States  |  Employees: 1637  |  Website: hims.com
Key Contacts
IR / Phone: 415 851 0195
Exchange: NYQ
Industry: Drug Manufacturers - Specialty & Generic
Quick Financial Snapshot
Revenue$1,476,514,000
Net Income$126,038,000
Free Cash Flow$198,334,000
Book Value / Share$2.21

Balance Sheet & Liquidity

Total Liabilities$230,823,000
Total Equity$476,716,000
Debt / Equity0.02
Current Ratio1.79
Interest CoverageN/A
Working Capital$174,464,000

Valuation Metrics

Core multiples and valuation signals — useful to compare vs peers.

P/E (TTM)41.43
Industry P/EN/A
Forward P/E136.43
P/B10.95
Price / Sales3.54
P / FCF26.33
EV / EBITDA63.45
Graham Number$5.38
DCF (placeholder)
Notes: red items typically indicate expensive multiples relative to fundamentals. Use the "Compare with industry" tool for context.

EPS (Annual)

Financial Performance

Revenue vs Net Income

Free Cash Flow (annual)

Profitability & Efficiency

Gross Margin 79.45%
Operating Margin 4.19%
Net Margin 8.54%
ROIC 22.29%
Asset Turnover 2.09

Automated Fundamental Signals (Score: 55)

Passed
  • EPS shows upward trend
  • Price CAGR 36.03%
  • ROIC 22.3%
  • Gross Margin 79.5%
  • P/FCF 26.33
  • Debt/Equity ratio
  • Positive Free Cash Flow
  • Current Ratio
  • Return on Tangible Assets
Failed
  • P/B Ratio 10.95
  • Operating Margin 4.2%
  • CapEx intensity
  • Interest Coverage
  • Debt/EBITDA
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)

Price Chart (Candlestick)

Technical Analysis (Score: 85)

RSI (14)62.52
SMA 5051.06
SMA 20045.04
MACD1.59
Signal BULLISH
RSI 62.5, SMA trend bullish, momentum 206.1%.

Governance & Management

Governance scores: Audit: 2 | Board: 8 | Compensation: 10 | Shareholder Rights: 10
Executive Team
NameTitle
Mr. Andrew Dudum Co-Founder, Chairman & CEO (1988)
Mr. Oluyemi Okupe Chief Financial Officer (1986)
Ms. Soleil Teubner Boughton J.D. Chief Legal Officer & Corporate Secretary (1978)
Dr. Patrick Carroll M.D. Chief Medical Officer & Director (1958)
Mr. Mike Chi Chief Commercial Officer (1980)
Mr. Nader Kabbani Chief Operations Officer (—)
Ms. Irene A. Becklund Senior VP, Controller & Principal Accounting Officer (1984)
Mr. Mohamed ElShenawy Chief Technology Officer (1974)
Governance data last updated: 10/1/2025

Latest News

No news available for this company.

← Back